PERFECT MEDICAL (01830) Issues Positive Profit Alert: Expected Interim Profit Attributable to Shareholders of Approximately HK$142 Million to HK$147 Million, Up Approximately 50% to 55% Year-on-Year

PERFECT MEDICAL (01830) announces that, based on the preliminary assessment by the Company's management of the unaudited consolidated management accounts of the Company and its subsidiaries (the Group) for the six months ended September 30, 2026 (the Period), the Group is expected to record profit attributable to shareholders for the Period of approximately HK$142 million to HK$147 million, representing a significant increase of approximately 50% to 55% as compared with the corresponding period in 2025. The expected significant increase in profit is primarily attributable to the following reasons: Digital transformation unlocking cost efficiencies and scalability Management has accelerated the digitalization of its business and streamlining of processes, comprehensively optimizing the cost structure, strengthening operating leverage, and building a sustainable growth platform with greater scale advantages. Streamlined network delivering stronger operating leverage The Group continues to optimize its service portfolio and network layout, systematically consolidating lower-productivity service centers, thereby enhancing overall operational efficiency and profitability and laying the foundation for better returns when demand recovers. Overseas markets gradually stabilizing and showing improving momentum Operations in Australia, Singapore and Macau are gradually stabilizing, with profitability improving, benefiting from disciplined network adjustments and an asset-light operating model. This provides a solid foundation for further expansion when market conditions improve.